Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: South Korea Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20084
20092
20101
20131
20141
20172
20192
20211
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
AstraZeneca3
Boehringer Ingelheim1
Eli Lilly and Company1
Genentech, Inc.1
Hanlim Pharm. Co., Ltd.1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive20
Emphysema3
Bronchitis, Chronic2
Bronchiolitis Obliterans Syndrome1
Hypertension, Pulmonary1
Lung Diseases1
Pneumonia1
Respiration Disorders1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.